Todd A Durham (Todd Durham)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Ophthalmology and therapy

Therapeutic innovation & regulatory science

University of North Carolina at Chapel Hill (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of North Carolina at Chapel Hill

United States

MSC :: Biostatistics

University of North Carolina at Chapel Hill

United States

PHD :: Health Policy and Management

Publications

M Dominik Fischer, Francesco Patalano, Christel Naujoks, Judit Banhazi, Christine Bouchet, Paul O'Brien, Christine Kay, Jane Green, Todd A Durham, Helena Bradley, Nicola Williamson, Melissa Barclay, Joel Sims, Isabelle Audo
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis. Ophthalmology and therapy (2023)
M Dominik Fischer, Francesco Patalano, Christel Naujoks, Judit Banhazi, Christine Bouchet, Paul O'Brien, Christine Kay, Jane Green, Todd A Durham, Helena Bradley, Nicola Williamson, Melissa Barclay, Joel Sims, Isabelle Audo
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis. Ophthalmology and therapy 12 (2) (2023)
M Dominik Fischer, Francesco Patalano, Christel Naujoks, Judit Banhazi, Christine Bouchet, Paul O'Brien, Christine Kay, Jane Green, Todd A Durham, Helena Bradley, Nicola Williamson, Melissa Barclay, Joel Sims, Isabelle Audo
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis. Ophthalmology and therapy 12 (2) (2023)
M Dominik Fischer, Francesco Patalano, Christel Naujoks, Judit Banhazi, Christine Bouchet, Paul O'Brien, Christine Kay, Jane Green, Todd A Durham, Helena Bradley, Nicola Williamson, Melissa Barclay, Joel Sims, Isabelle Audo
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis. Ophthalmology and therapy 12 (2) (2023)
Isabelle Audo, Francesco Patalano, Christel Naujoks, Claudio Spera, M Dominik Fischer, Jane Green, Christine Kay, Todd A Durham, Nicola Williamson, Helena Bradley, Melissa Barclay, Kieran Boparai, Judit Banhazi
Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO. Ophthalmology and therapy (2023)
M Dominik Fischer, Francesco Patalano, Christel Naujoks, Judit Banhazi, Christine Bouchet, Paul O'Brien, Christine Kay, Jane Green, Todd A Durham, Helena Bradley, Nicola Williamson, Melissa Barclay, Joel Sims, Isabelle Audo
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis. Ophthalmology and therapy 12 (2) (2023)
Todd A Durham
How Did These Data Get Here? Recommendations for the Analysis of Data From ClinicalTrials.gov. Therapeutic innovation & regulatory science 53 (5) (2018)

Todd A Durham.css-eqlu8i{font-size:small;padding-left:4px;} (Todd Durham)

Publication Activity (10 Years)

Top Topics

Top Venues

Todd A Durham (Todd Durham)